The New Era of Inflammatory Disease Management Through the Application of Biosimilar Therapeutics
The New Era of Inflammatory Disease Management Through the Application of Biosimilar Therapeutics is organized by AcademicCME.
Program Dates: March 31st, 2023 - March 30th, 2024
Program Overview:
While biosimilar therapeutics have been widely available for some time for the treatment inflammatory conditions, many pharmacists, managed care professionals, and other healthcare providers have not had a recent opportunity to investigate data showing the interchangeable safety and efficacy alignment between approved biosimilar therapeutics and their less accessible referent medications. In addition to interchangeability, concepts involving extrapolation and the shifting of a treatment plan to include biosimilar equivalents may not have made clear inroads into the daily practice of those involved in medication distribution and formulary management. A clinical update on these concepts for pharmacists, managed care professionals, and related healthcare providers, can help reduce or remove serious barriers to care affecting patients with inflammatory bowel and joint diseases.
Learning Objectives:
• Review current on the developmental and clinical trial process of biosimilar therapies and recent advances in the use of biosimilars to treat inflammatory bowel disease and rheumatological disorders.
• Analyze recent clinical trial data and review practical approaches for the use of biosimilars, including interchangeability and switching.
• Develop strategies to communicate with the interprofessional team and educate patients on biosimilars, including issues of varying patient perceptions.
Additional details will be posted as soon as information is available.